dlt446 dlt446

dlt446 dlt446

Clinical Professor

Member of:

  • Neurology


  1. 2019
  2. Published

    Correction to: Therapeutic novelties in migraine: new drugs, new hope?

    Do, T. P., Guo, S. & dlt446, dlt446, 1 Dec 2019, In: The Journal of Headache and Pain. 20, 1, 1 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  3. Published

    Investigation of distinct molecular pathways in migraine induction using calcitonin gene-related peptide and sildenafil

    Younis, S., Christensen, C. E., Toft, N. M., Søborg, T., Amin, Faisal Mohammad, Hougaard, A. & dlt446, dlt446, Dec 2019, In: Cephalalgia. 39, 14, p. 1776-1788

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions

    dlt446, dlt446, Kudrow, D., Reuter, U., Dolezil, D., Silberstein, S., Tepper, S. J., Xue, F., Picard, H., Zhang, F., Wang, A., Zhou, Y., Hong, F., Klatt, J. & Mikol, D. D., Dec 2019, In: Cephalalgia. 39, 14, p. 1798-1808

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Board Walk – October 2019

    dlt446, dlt446, 1 Oct 2019, In: Cephalalgia. 39, 11, p. 1470-1471 2 p.

    Research output: Contribution to journalEditorialResearchpeer-review

  6. Published

    Acute and preventive pharmacological treatment of post-traumatic headache: a systematic review

    Larsen, E. L., Ashina, H., Iljazi, A., Al-Khazali, H. M., Seem, K., dlt446, dlt446, Ashina, S. & Schytz, Henrik Winther, Oct 2019, In: Journal of Headache and Pain. 20, 9 p., 98.

    Research output: Contribution to journalReviewResearchpeer-review

  7. Published

    Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine

    dlt446, dlt446, Goadsby, P. J., Reuter, U., Silberstein, S., Dodick, D., Rippon, G. A., Klatt, J., Xue, F., Chia, V., Zhang, F., Cheng, S. & Mikol, D. D., Oct 2019, In: Cephalalgia. 39, 11, p. 1455-1464

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial

    Diener, H. C., Goadsby, P. J., dlt446, dlt446, Al-Karagholi, M. A. M., Sinclair, A., Mitsikostas, D., Magis, D., Pozo-Rosich, P., Irimia Sieira, P., Làinez, M. J. A., Gaul, C., Silver, N., Hoffmann, J., Marin, J., Liebler, E. & Ferrari, M. D., Oct 2019, In: Cephalalgia. 39, 12, p. 1475-1487

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Association Between Sumatriptan Treatment During a Migraine Attack and Central 5-HT1B Receptor Binding

    Deen, M., Hougaard, A., Hansen, H. D., Schain, M., Dyssegaard, A., Knudsen, Gitte Moos & dlt446, dlt446, 1 Jul 2019, In: JAMA Neurology. 76, 7, p. 834-840 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Adherence to the 2008 IHS guidelines for controlled trials of drugs for the preventive treatment of chronic migraine in adults

    Deen, M., Martinelli, D., Pijpers, J., Diener, H. C., Silberstein, S., Ferrari, M. D., dlt446, dlt446, Tassorelli, C. & Yuan, H., Jul 2019, In: Cephalalgia. 39, 8, p. 1058-1066

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial

    Tepper, S. J., Diener, H. C., dlt446, dlt446, Brandes, J. L., Friedman, D. I., Reuter, U., Cheng, S., Nilsen, J., Leonardi, D. K., Lenz, R. A. & Mikol, D. D., May 2019, In: Neurology. 92, 20, p. E2309-E2320

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition

    on behalf of the International Headache Society Clinical Trials Standing Committee, O. B. O. T. I. H. S. C. T. S. C., May 2019, In: Cephalalgia. 39, 6, p. 687-710

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    Effect of hypoxia on BOLD fMRI response and total cerebral blood flow in migraine with aura patients

    Arngrim, N., Hougaard, A., Schytz, Henrik Winther, Vestergaard, M. B., Britze, J., Amin, Faisal Mohammad, Olsen, K. S., Larsson, Henrik Bo Wiberg, Olesen, Jes & dlt446, dlt446, Apr 2019, In: Journal of Cerebral Blood Flow and Metabolism. 39, 4, p. 680-689 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published

    Neurovascular origin of primary headaches

    dlt446, dlt446 & Ayata, C., Apr 2019, In: Journal of Cerebral Blood Flow and Metabolism. 39, 4, p. 571-572

    Research output: Contribution to journalEditorialResearchpeer-review

  15. Published

    Therapeutic novelties in migraine: new drugs, new hope?

    Do, T. P., Guo, S. & dlt446, dlt446, Apr 2019, In: Journal of Headache and Pain. 20, 13 p., 37.

    Research output: Contribution to journalReviewResearchpeer-review

  16. Published

    CGRP in Human Models of Migraine

    Ashina, H., Schytz, Henrik Winther & dlt446, dlt446, 2019, Calcitonin Gene-Related Peptide (CGRP) Mechanisms. Brian, S. & Geppetti, P. (eds.). Springer, Vol. 255. p. 109-120 (Handbook of Experimental Pharmacology).

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

  17. Published

    CGRP, a target for preventive therapy in migraine and cluster headache: Systematic review of clinical data

    Khan, S., Olesen, A. & dlt446, dlt446, 2019, In: Cephalalgia : an international journal of headache. 39, 3, p. 374-389 16 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. Published

    Calcitonin gene-related peptide - beyond migraine prophylaxis

    Olesen, Jes & dlt446, dlt446, 2019, In: Nature Reviews. Neurology. 15, 10, p. 562-564 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. Published

    Calcitonin-gene related peptide and disease activity in cluster headache

    Snoer, A., Vollesen, A. L. H., Beske, R. P., Guo, S., Hoffmann, J., Fahrenkrug, J., Jørgensen, Niklas Rye, Martinussen, Torben, Jensen, Rigmor Højland & dlt446, dlt446, 2019, In: Cephalalgia. 39, 5, p. 575-584

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published

    Cortical abnormalities in episodic migraine: A multi-center 3T MRI study

    Magon, S., May, A., Stankewitz, A., Goadsby, P. J., Schankin, C., dlt446, dlt446, Amin, Faisal Mohammad, Seifert, C. L., Mallar Chakravarty, M., Müller, J. & Sprenger, T., 2019, In: Cephalalgia. 39, 5, p. 665-673 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  21. Published

    Current understanding of thalamic structure and function in migraine

    Younis, S., Hougaard, A., Noseda, R. & dlt446, dlt446, 2019, In: Cephalalgia. 39, 13, p. 1675-1682 8 p.

    Research output: Contribution to journalReviewResearchpeer-review

  22. Published

    Effect of pituitary adenylate cyclase-activating polypeptide-27 on cerebral hemodynamics in healthy volunteers: A 3T MRI study

    Ghanizada, H., Al-Karagholi, M. A. M., Arngrim, N., Ghanizada, M., Larsson, Henrik Bo Wiberg, Amin, Faisal Mohammad & dlt446, dlt446, 2019, In: Peptides. 121, 170134.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published

    Effect of the H 1 -antihistamine clemastine on PACAP38 induced migraine

    Vollesen, L. H., Guo, S., Andersen, M. R. & dlt446, dlt446, 2019, In: Cephalalgia. 39, 5, p. 597-607 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  24. Published

    European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention

    Sacco, S., Bendtsen, Lars, dlt446, dlt446, Reuter, U., Terwindt, G., Mitsikostas, D. & Martelletti, P., 2019, In: The Journal of Headache and Pain. 20, 33 p., 6.

    Research output: Contribution to journalJournal articleResearchpeer-review

  25. Published

    Extracranial activation of ATP-sensitive potassium channels induces vasodilation without nociceptive effects

    Al-Karagholi, M. A., Ghanizada, H., Hansen, J. M., Aghazadeh, S., Skovgaard, Lene Theil, Olesen, Jes & dlt446, dlt446, 2019, In: Cephalalgia. 39, 14, p. 1789-1797 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  26. Published

    Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial

    Ferrari, M. D., Diener, H. C., Ning, X., Galic, M., Cohen, J. M., Yang, R., Mueller, M., Ahn, A. H., Schwartz, Y. C., Grozinski-Wolff, M., Janka, L. & dlt446, dlt446, 2019, In: The Lancet. 394, 10203, p. 1030-1040 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 Next

ID: 920785